Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
2.950
-0.050 (-1.67%)
At close: Jul 14, 2025, 4:00 PM
2.970
+0.020 (0.67%)
After-hours: Jul 14, 2025, 4:49 PM EDT
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $10.86 million as of July 14, 2025. Its market cap has increased by 417.07% in one year.
Market Cap
10.86M
Enterprise Value
13.14M
1-Year Change
417.07%
Ranking
Category
Stock Price
$2.95
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $160.50M to $10.86M, a decrease of -93.23%. That is a compound annual growth rate of -25.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 1.20M | -45.45% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.27% |
| Dec 31, 2021 | 38.40M | -74.67% |
| Dec 31, 2020 | 151.60M | 413.90% |
| Dec 31, 2019 | 29.50M | 2.08% |
| Dec 31, 2018 | 28.90M | -68.17% |
| Dec 29, 2017 | 90.80M | 85.69% |
| Dec 30, 2016 | 48.90M | -69.53% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |